Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1-based Therapy Discontinuation

NCT07729332 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07729332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07729332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1-based Therapy Discontinuation
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
July 31, 2031
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity